Helen Mach

Helen Mach

Auto-generated profile, based on publicly available information

Helen Mach

Department of Communication Sciences and Disorders, University of Delaware, Newark

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 April 2024 in Proceedings of the ACM on Human-Computer Interaction
Verified
Journal Article
Open access
JCJosh Cherian
Josh Cherian
SRSamantha Ray
Samantha Ray
TMThomas Mernar
Thomas Mernar
PTPaul Taele
Paul Taele
HMHelen Mach
Helen Mach
THTracy Anne Hammond
Tracy Anne Hammond
The past several decades have seen significant advances in monitoring older adults' health and well-being. However, creating viable, practical monitoring systems for informing caregivers requires understanding which behaviors and signs to track and what approaches best present that information. To investigate how technology can be leveraged to better augment caregivers' workflows, we take a multi-stage, qualitative approach to gain insights into the needs of caregivers and the older adults receiving care. Specifically, we use a series of domain expert interviews, cognitive walkthroughs, and semi-structured interviews with residents, and we synthesize our takeaways using thematic analysis at each phase. Our results show that this type of monitoring technology has great potential to reduce the effort needed by caregivers to complete their responsibilities and communicate with their teams. Additionally, we found that older adults are receptive to the technology but their privacy and autonomy must be prioritized for the sake of their mental wellbeing. These insights will facilitate greater intelligent interface development for Person-Centered Care by identifying important design considerations and vital features that require system support.

20 February 2021 in PM&R
Verified
Journal Article
Closed access
PDF file
HMHelen Mach
Helen Mach
CBCarolyn Baylor
Carolyn Baylor
MBMichael Burns
Michael Burns
KYKathryn Yorkston
Kathryn Yorkston

19 October 2023 in International Journal of Language & Communication Disorders
Verified
Journal Article
Closed access
CBCarolyn Baylor
Carolyn Baylor
JJJingyu Linna Jin
Jingyu Linna Jin
HMHelen Mach
Helen Mach
DBDeanna Britton
Deanna Britton

1 January 2021 in American Journal of Speech-Language Pathology
Verified
Journal Article
Closed access
HMHelen Mach
Helen Mach
CBCarolyn Baylor
Carolyn Baylor
RPRebecca Hunting Pompon
Rebecca Hunting Pompon
KYKathryn Yorkston
Kathryn Yorkston
Purpose: Family members of people with Parkinson's disease (PD) may experience third-party disability, manifesting as difficulty managing communication breakdowns and changed relationships influenced by communication disorders. This study examined family involvement in therapy to address third-party disability from the perspective of family members of people with PD and speech-language pathologists (SLPs). Method: A mixed-methods design was used with two phases of data collection. In Phase 1 qualitative interviews, nine family members shared their perspectives about their involvement in therapy. In Phase 2, a survey was developed from Phase 1 data to gather data from SLPs (N = 110) on their clinical practices involving family members. Results: Family members and SLPs agreed that when family were involved in therapy, it was primarily to support therapy exercises for the person with PD. Many SLPs reported providing supportive activities for family members. However, qualitative data from family members suggested that the limited involvement they had in therapy did not sufficiently meet their unique needs resulting from communication changes with the person with PD and other related challenges. Constraints influencing family member involvement included insurance billing regulations, privacy laws for patients, and family members' availability. Conclusions: While some families and SLPs reported efforts to specifically include families and address their needs in therapy, these practices were inconsistent and, from families' perspectives, insufficient to meet their own needs. Future research should consider family-centered approaches that involve family members in speech-language therapy to enhance their daily lives, along with persons with PD.

3 July 2024 in American Journal of Speech-Language Pathology
Verified
Journal Article
Closed access
KGKelly Gates
Kelly Gates
TKThea Knowles
Thea Knowles
HMHelen Mach
Helen Mach
JHJeff Higginbotham
Jeff Higginbotham
Purpose: The purpose of this qualitative interview study was to identify themes regarding considerations in the usage of speech amplification device usage for people with Parkinson's disease (PD) and hypophonia from the perspective of speech-language pathologists (SLPs). Method: Eligible participants included SLPs currently practicing in the United States or Canada with experience working with clients with PD for at least 2 years. Ten SLPs participated in 60-min interviews conducted via Zoom. A semistructured interview guide was created prior to the interviews. The interviews were transcribed following their completion, and an iterative coding process was used to identify themes using thematic analysis. Results: Three main themes were identified from the interviews. The first theme encapsulated how clinicians described amplification devices as a potential treatment tool, which highlighted the nuances that may impact selecting an amplification device as a treatment option such as increased hypophonia or dysarthria severity and cognitive decline. The second theme highlighted how device selection depends on the individual needs of the user. Individual client characteristics (such as disease symptoms and individual needs and preferences) may impact the choice of amplification device. The last theme outlined the importance of involving family members in all stages of device use and involving other health care team members on a case-by-case basis. Conclusions: The insights provided by the SLP participants help to understand the clinical decisions that are made when determining device candidacy, selecting a device, and evaluating device success. These insights can be used to improve research studies of augmentative management of hypophonia and guide more personalized management decisions.

3 July 2024 in American Journal of Speech-Language Pathology
Verified
Journal Article
Closed access
KGKelly Gates
Kelly Gates
TKThea Knowles
Thea Knowles
HMHelen Mach
Helen Mach
JHJeff Higginbotham
Jeff Higginbotham
THThea Holder
Thea Holder
Purpose: The purpose of this study was to survey speech-language pathologists (SLPs) who assess and treat people with Parkinson's disease (PD) to gather insights into their decision making regarding their use or potential use of speech amplification technology for the management of hypophonia. Method: A total of 111 SLPs who were currently practicing in the United States or Canada and had experience working with clients with PD for at least 2 years completed an anonymous Qualtrics survey. Questions were designed to probe the following areas: (a) degree of familiarity with amplification devices as a form of treatment for PD, (b) attitudes and perceptions of the implementation of these devices for PD, and (c) factors that influence the clinical decision to prescribe such devices. Results: Most participants (75; 71%) reported they had considered prescribing a device to at least one client with PD. When asked at which stages of speech or voice impairment they would consider the use of an amplification device for clients with PD, the most common response was for clients with moderate or severe hypophonia who were not stimulable for louder speech. However, 36 (32%) respondents indicated they would also consider an amplification device for clients who were stimulable for louder speech with severe hypophonia. When asked to rank the most important factors they would weigh when considering the prescription of an amplification device, they ranked the client's preference and comfort level as the most important consideration. Conclusion: This study provides valuable clinical insights regarding how SLPs can approach utilizing speech amplification devices in the therapy environment.